Process for preparing a dry powder formulation comprising an anticholinergic, a corticosteroid and a beta-adrenergic

US10350164B2 · kind B2 · utility

Assignee

• Chiesi Farmaceutici S.p.A. · IT

Inventors

• Alessandro Cavecchi · Parma, IT
• Cristiana Merusi · Parma, IT
• Fausto Pivetti · Parma, IT
• Francesca Schiaretti · Parma, IT

Key dates

• Filing date: May 9, 2018
• Grant date: Jul 16, 2019
• Expiry date: May 9, 2038

Classification

• Technology area (CPC A): Human Necessities
• CPC primary: A61K2300/00
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

A process for preparing a dry powder formulation for inhalation comprising a combination of an anti-cholinergic, a long-acting beta2-adrenoceptor agonist, and, optionally, an inhaled corticosteroid, is provided.